Literature DB >> 17472505

First do no harm... Terminal restlessness or drug-induced delirium.

Clare White1, Mary Ann McCann, Neil Jackson.   

Abstract

Terminal restlessness is a term frequently used to refer to a clinical spectrum of unsettled behaviors in the last few days of life. Because there are many similarities between the clinical pictures observed in terminal restlessness and delirium, we postulate that at times what is referred to as terminal restlessness may actually be an acute delirium sometimes caused by medication used for symptom control. It is important therefore to consider the causes for this distressing clinical entity, treat it appropriately, and ensure the treatment provided does not increase its severity. This brief review aims to consider the medications that are commonly used toward the end of life that may result in a picture of delirium (or terminal restlessness). These include opioids, antisecretory agents, anxiolytics, antidepressants, antipsychotics, antiepileptics, steroids and nonsteroidal anti-inflammatory drugs (NSAIDs). This review also aims to raise awareness regarding the recognition and diagnosis of delirium and to highlight the fact that delirium may be reversible in up to half of all cases. Good management of delirium has the potential to significantly improve patient care at the end of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472505     DOI: 10.1089/jpm.2006.0112

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  5 in total

Review 1.  Antipsychotic-induced akathisia in delirium: A systematic review.

Authors:  Fernando Espi Forcen; Konstantina Matsoukas; Yesne Alici
Journal:  Palliat Support Care       Date:  2015-06-19

2.  Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication.

Authors:  David Hui; Allison De La Rosa; Diana L Urbauer; Thuc Nguyen; Eduardo Bruera
Journal:  Cancer       Date:  2021-08-25       Impact factor: 6.860

3.  Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life.

Authors:  Michael J Hochman; Arif H Kamal; Steven P Wolf; Greg P Samsa; David C Currow; Amy P Abernethy; Thomas W LeBlanc
Journal:  J Pain Symptom Manage       Date:  2016-09-20       Impact factor: 3.612

4.  Antipsychotic-induced akathisia in cancer settings.

Authors:  Fernando Espi Forcen; James C Root; Yesne Alici
Journal:  Psychooncology       Date:  2016-09-06       Impact factor: 3.894

Review 5.  Clinical Assessment and Management of Delirium in the Palliative Care Setting.

Authors:  Shirley Harvey Bush; Sallyanne Tierney; Peter Gerard Lawlor
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.